Why hypertensive patients vary in their response to oral debrisoquine.
about
Determination of debrisoquine metabolic ratio from hourly urine collections in healthy volunteers.Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studiesDrug resistance, inappropriate dosing and non-compliance in hypertensive patients.The disposition of debrisoquine in hypertensive patients.Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neuroneConcentration of debrisoquine by human platelets in vivo: relationship to hypotensive effect [proceedings]Genetic aspects of drug disposition and therapeutics.Strength and weakness of phase I to IV trials, with an emphasis on translational aspects.Personalized Drug Dosage - Closing the Loop.Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices.Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and TherapeuticsQuality use of medicines: where does pharmacology 'end'? Invited ASCEPT Lecture. Australasian Society of Clinic and Experimental Pharmacologists and Toxicologists.A collection of therapeutic, toxic and fatal blood drug concentrations in man.
P2860
Q34417415-CEED43F5-3B19-45C6-9ACE-F63A77646739Q34447046-CFF38B84-1827-4A81-9CEC-C451448D57DCQ34518772-00B70F21-EC21-4FCA-AD6E-0A8B228C96A0Q34707745-283BD3BC-04D3-4BE6-86F6-FC9D0ECDEB55Q34718199-AD4AA0DA-A08A-4CB0-BDDD-0FA60146F832Q34739424-CFF48C71-2309-4FD3-A067-156F2D33775DQ36244452-9BB76BA1-8F33-4E38-8047-7D3BAAD99D40Q37039810-3BACB642-4614-4A67-8212-3FDEA99F6CE1Q40956598-CF049DB2-67A4-45AB-A8D0-18F31BF1F2EAQ41760769-BF71B6F0-BE15-4EB8-B3B1-8E5E50A16AC2Q42250442-482B8DC8-4A12-4C14-AC1D-C22FE2A23C2CQ42361532-87C595BC-3992-4B09-B011-CE0EA6900E55Q48579867-B8EE235F-CC22-4075-8DC7-032067F7EEF1Q50171561-8F1C9C3F-CA15-4B00-AF5A-347D805FDCF5
P2860
Why hypertensive patients vary in their response to oral debrisoquine.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Why hypertensive patients vary in their response to oral debrisoquine.
@en
Why hypertensive patients vary in their response to oral debrisoquine.
@nl
type
label
Why hypertensive patients vary in their response to oral debrisoquine.
@en
Why hypertensive patients vary in their response to oral debrisoquine.
@nl
prefLabel
Why hypertensive patients vary in their response to oral debrisoquine.
@en
Why hypertensive patients vary in their response to oral debrisoquine.
@nl
P2093
P2860
P356
P1433
P1476
Why hypertensive patients vary in their response to oral debrisoquine.
@en
P2093
P2860
P304
P356
10.1136/BMJ.1.6058.422
P407
P577
1977-02-01T00:00:00Z